MedTrace Logo

Meridian Energy Changes of Head and Neck Cancer Patients After Chemotherapy or Radiotherapy

NCT04872517 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2023-09-07

No results posted yet for this study

Summary

This trial is conducted by using MEAD to detect the meridian changes in patients with head and neck cancer after conventional treatment of chemotherapy or radiotherapy.

Conditions

Interventions

DEVICE

Meridian Electroacupuncture Analysis Device (MEAD)

use MEAD to detect energy change in patient with head and neck cancer

Sponsors & Collaborators

  • Liao Jian An

    lead OTHER

Principal Investigators

  • Jian-An Liao · medical attending

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2023-12-31
Completion
2024-03-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04872517 on ClinicalTrials.gov